Substitutes for Maxvoid Plus 8 CP Tablet
Composition: Dutasteride 0.5mg + Silodosin 8mg
Maxvoid Plus 8 CP Tablet is out of stock right now
Good news — 5 medicines with the same composition are listed below and can be ordered instead.
Save up to ₹856.61 (66%) with a generic
Cheapest in-stock substitute: SILDONIL-8D
You're viewing
Maxvoid Plus 8 CP Tablet
RxAlkem Laboratories Ltd
₹1300 Out of stock
View details Same composition & strength
3A like-for-like swap — identical active ingredients, same strength and form as Maxvoid Plus 8 CP Tablet.
Same molecule — other strengths or forms
2Same active ingredient(s) but a different strength or form — check the strength matches your prescription.
Rx Required
Neodosin-D Capsule
Neo Biotech
Silodosin8mg+1
₹415
Out of Stock Save ₹885 (68% off)
About these molecules
Dutasteride0.5mg
Full details →Dutasteride is a 5-alpha reductase inhibitor used to treat benign prostatic hyperplasia (BPH). It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), reducing prostate size. Dutasteride is effective in managing urinary symptoms associated with BPH. In summary, Dutasteride is beneficial for treating prostate enlargement.
Silodosin8mg
Full details →Silodosin is an alpha-blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing muscles in the prostate and bladder neck, improving urine flow. This medication is crucial for managing urinary symptoms associated with BPH. In summary, Silodosin is effective in treating BPH.
Why a generic substitute?
Same active ingredient
A substitute has the exact same salt(s) — so it works the same way as the brand.
Often much cheaper
Generics can cost a fraction of the branded price for the identical molecule.
Quality-regulated
All medicines we list are from licensed sellers and meet the same standards.
Substitutes share the same active ingredients, but always confirm the strength and form with your doctor or pharmacist before switching — especially for chronic, prescription or narrow-therapeutic-index medicines.